The Gut and Parkinson's Disease-A Bidirectional Pathway
- PMID: 31214110
- PMCID: PMC6558190
- DOI: 10.3389/fneur.2019.00574
The Gut and Parkinson's Disease-A Bidirectional Pathway
Abstract
Humans evolved a symbiotic relationship with their gut microbiome, a complex microbial community composed of bacteria, archaea, protists, and viruses, including bacteriophages. The enteric nervous system (ENS) is a gateway for the bidirectional communication between the brain and the gut, mostly through the vagus nerve (VN). Environmental exposure plays a pivotal role in both the composition and functionality of the gut microbiome and may contribute to susceptibility to neurodegenerative disorders, such as Parkinson's disease (PD). The neuropathological hallmark of PD is the widespread appearance of alpha-synuclein aggregates in both the central and peripheral nervous systems, including the ENS. Many studies suggest that gut toxins can induce the formation of α-syn aggregates in the ENS, which may then be transmitted in a prion-like manner to the CNS through the VN. PD is strongly associated with aging and its negative effects on homeostatic mechanisms protecting from inflammation, oxidative stress, and protein malfunction. In this mini-review, we revisit some landmark discoveries in the field of Parkinson's research and focus on the gut-brain axis. In the process, we highlight evidence showing gut-associated dysbiosis and related microbial-derived components as important players and risk factors for PD. Therefore, the gut microbiome emerges as a potential target for protective measures aiming to prevent PD onset.
Keywords: Parkinson's disease; enteric nervous system; microbiome; neurotoxicants; probiotics.
Figures

Similar articles
-
The Gut-Brain Axis: Two Ways Signaling in Parkinson's Disease.Cell Mol Neurobiol. 2022 Mar;42(2):315-332. doi: 10.1007/s10571-021-01066-7. Epub 2021 Mar 2. Cell Mol Neurobiol. 2022. PMID: 33649989 Free PMC article. Review.
-
Altered gut microbiota and intestinal permeability in Parkinson's disease: Pathological highlight to management.Neurosci Lett. 2019 Nov 1;712:134516. doi: 10.1016/j.neulet.2019.134516. Epub 2019 Sep 24. Neurosci Lett. 2019. PMID: 31560998 Review.
-
Microbiome-based therapies for Parkinson's disease.Front Nutr. 2024 Nov 6;11:1496616. doi: 10.3389/fnut.2024.1496616. eCollection 2024. Front Nutr. 2024. PMID: 39568727 Free PMC article. Review.
-
The Gut and Nonmotor Symptoms in Parkinson's Disease.Int Rev Neurobiol. 2017;134:787-809. doi: 10.1016/bs.irn.2017.05.027. Epub 2017 Jul 3. Int Rev Neurobiol. 2017. PMID: 28805583 Review.
-
Nigral overexpression of α-synuclein in a rat Parkinson's disease model indicates alterations in the enteric nervous system and the gut microbiome.Neurogastroenterol Motil. 2020 Jan;32(1):e13726. doi: 10.1111/nmo.13726. Epub 2019 Oct 2. Neurogastroenterol Motil. 2020. PMID: 31576631
Cited by
-
The Current State-of-the Art of LRRK2-Based Biomarker Assay Development in Parkinson's Disease.Front Neurosci. 2020 Aug 18;14:865. doi: 10.3389/fnins.2020.00865. eCollection 2020. Front Neurosci. 2020. PMID: 33013290 Free PMC article. Review.
-
Patient-Derived Midbrain Organoids to Explore the Molecular Basis of Parkinson's Disease.Front Neurol. 2020 Sep 4;11:1005. doi: 10.3389/fneur.2020.01005. eCollection 2020. Front Neurol. 2020. PMID: 33013664 Free PMC article. Review.
-
A Pitx3-deficient developmental mouse model for fine motor, olfactory, and gastrointestinal symptoms of Parkinson's disease.Neurobiol Dis. 2022 Aug;170:105777. doi: 10.1016/j.nbd.2022.105777. Epub 2022 May 27. Neurobiol Dis. 2022. PMID: 35636646 Free PMC article.
-
Gut and Brain: Investigating Physiological and Pathological Interactions Between Microbiota and Brain to Gain New Therapeutic Avenues for Brain Diseases.Front Neurosci. 2021 Oct 12;15:753915. doi: 10.3389/fnins.2021.753915. eCollection 2021. Front Neurosci. 2021. PMID: 34712115 Free PMC article. Review.
-
Chronic Effects of Dietary Pesticides on the Gut Microbiome and Neurodevelopment.Front Microbiol. 2022 Jun 30;13:931440. doi: 10.3389/fmicb.2022.931440. eCollection 2022. Front Microbiol. 2022. PMID: 35847088 Free PMC article. Review.
References
-
- Doty RL, Deems DA, Stellar S. Olfactory dysfunction in parkinsonism A general deficit unrelated to neurologic signs, disease stage, or disease duration. Neurology. (1988) 38:1237–1237. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous